Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MLKL | Q8NB16 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9979794 | 0.89 | AOC3 (0.34) | TSHR | |
| SCHEMBL10045842 | 0.80 | ALDH1A1 (0.31) | ALDH1A1MAPT | |
| SCHEMBL21769395 | 0.80 | ESR1 (0.50) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL17124666 | 0.80 | TSHR (0.36) | ACHEKMT2ATSHR | |
| SCHEMBL13283559 | 0.80 | TYR (0.41) | ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL6206391 | 0.78 | AOC3 (0.44) | ALDH1A1MAPTACHEMEN1KMT2A | |
| SCHEMBL6202340 | 0.78 | CYP1A2 (0.42) | ALDH1A1MAPTMEN1KMT2AALOX5 | |
| SCHEMBL6205818 | 0.78 | CA12 (0.52) | ALDH1A1MAPTACHETDP1TSHR | |
| SCHEMBL20960412 | 0.78 | TDP1 (0.42) | ALDH1A1MAPTACHETDP1MEN1 | |
| SCHEMBL10186917 | 0.78 | IDO1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105658089-A | Organic compounds | 奇华顿股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| EP-1435978-B1 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | CRODA INC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-20110083730-A1 | DERIVATIVES OR DIPYRANNYLIDENE TYPE AS ANODE INTERFACE LAYER IN ELECTRONIC DEVICES | COMMISSARIAT A L'ENERGIE ATOMIQUE | 2011-04-14 | — | — | US | disclosed |
| EP-1984331-B1 | PYRROLIDINE DERIVATIVES AS ERK INHIBITORS | SCHERING CORP (US) | 2010-10-20 | — | — | EP | disclosed |
| EP-1506175-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097609-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110083730-A1 | DERIVATIVES OR DIPYRANNYLIDENE TYPE AS ANODE INTERFACE LAYER IN ELECTRONIC DEVICES | OCIAD2, OCIAD1, OSTC | CHRNA7 2953/4885ALDH1A1 156/4885MAPT 765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.